A Randomized, Open-label, Single-center, Two-cycle, Two-crossover Phase I Clinical Trial Evaluating the Effect of Food on the Pharmacokinetics of TQ05105 Tablets in Healthy Adult Subjects
Latest Information Update: 07 Aug 2024
At a glance
- Drugs Rovadicitinib (Primary)
- Indications Myelofibrosis
- Focus Pharmacokinetics
- Sponsors Chia Tai Tianqing Pharmaceutical Group
- 10 Aug 2023 New trial record